These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 16699777)

  • 41. Nonadenomatous tumors of the pituitary and sella turcica.
    Huang BY; Castillo M
    Top Magn Reson Imaging; 2005 Jul; 16(4):289-99. PubMed ID: 16785844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients.
    Mazal PR; Czech T; Sedivy R; Aichholzer M; Wanschitz J; Klupp N; Budka H
    Clin Neuropathol; 2001; 20(4):163-71. PubMed ID: 11495005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrasellar gangliocytoma containing gastrin and growth hormone-releasing hormone associated with a growth hormone-secreting pituitary adenoma.
    Bevan JS; Asa SL; Rossi ML; Esiri MM; Adams CB; Burke CW
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):213-24. PubMed ID: 2512034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A clinico-pathologic study of pituitary adenomas.
    Sarkar C; Roy S; Kochupillai N; Gupta N; Tandon PN
    Indian J Med Res; 1990 Oct; 92():315-23. PubMed ID: 2272669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytomorphologic spectrum of mixed pituitary adenoma-gangliocytomas: a report of two cases.
    Sy J; Ang LC
    Acta Cytol; 2010; 54(5 Suppl):981-4. PubMed ID: 21053582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carcinomas of the pituitary: definition and review of the literature.
    Lübke D; Saeger W
    Gen Diagn Pathol; 1995 Oct; 141(2):81-92. PubMed ID: 8548598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apoptosis in human pituitary adenomas: a morphologic and in situ end-labeling study.
    Kontogeorgos G; Sambaziotis D; Piaditis G; Karameris A
    Mod Pathol; 1997 Sep; 10(9):921-6. PubMed ID: 9310956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pathological analysis of 1458 cases of tumor in the sella turcica region].
    Lu DH; Xu QZ
    Zhonghua Zhong Liu Za Zhi; 1988 May; 10(3):205-8. PubMed ID: 3219981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunocytochemistry of prolactin-producing human pituitary adenomas.
    Duello TM; Halmi NS
    Am J Anat; 1980 Aug; 158(4):463-9. PubMed ID: 7006374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pituitary adenoma with gangliocytic component: report of 5 cases with focus on immunoprofile of gangliocytic component.
    Balci S; Saglam A; Oruckaptan H; Erbas T; Soylemezoglu F
    Pituitary; 2015 Feb; 18(1):23-30. PubMed ID: 24430434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathologic correlates of giant pituitary adenomas.
    Chacko G; Chacko AG; Lombardero M; Mani S; Seshadri MS; Kovacs K; Scheithauer BW
    J Clin Neurosci; 2009 May; 16(5):660-5. PubMed ID: 19285407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production of alpha-subunit of glycoprotein hormones by pituitary somatotroph adenomas in vitro.
    Kontogeorgos G; Asa SL; Kovacs K; Smyth HS; Singer W
    Acta Endocrinol (Copenh); 1993 Dec; 129(6):565-72. PubMed ID: 7509101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acidophil stem cell adenoma of the human pituitary.
    Horvath E; Kovacs K; Singer W; Ezrin C; Kerenyi NA
    Arch Pathol Lab Med; 1977 Nov; 101(11):594-9. PubMed ID: 199135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined gangliocytoma and prolactinoma of the pituitary gland.
    Mikami S; Kameyama K; Takahashi S; Yoshida K; Kawase T; Sano T; Mukai M
    Endocr Pathol; 2008; 19(2):117-21. PubMed ID: 18651251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas.
    Tampanaru-Sarmesiu A; Stefaneanu L; Thapar K; Kovacs K; Donnelly T; Metz CN; Bucala R
    Arch Pathol Lab Med; 1997 Apr; 121(4):404-10. PubMed ID: 9140312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
    Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
    Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An overview of pituitary tumors.
    Berry RG; Caplan HJ
    Ann Clin Lab Sci; 1979; 9(2):94-102. PubMed ID: 222198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical survey of migration of human anterior pituitary cells in developmental, pathological, and clinical aspects: a review.
    Hori A; Schmidt D; Kuebber S
    Microsc Res Tech; 1999 Jul; 46(1):59-68. PubMed ID: 10402273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Collision sellar lesions: experience with eight cases and review of the literature.
    Koutourousiou M; Kontogeorgos G; Wesseling P; Grotenhuis AJ; Seretis A
    Pituitary; 2010; 13(1):8-17. PubMed ID: 19551516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolactin-containing pituitary adenomas. Their characteristics and comparative study with non-prolactin adenomas.
    Ho DM; Liu HC
    Pathol Res Pract; 1992 Apr; 188(3):296-302. PubMed ID: 1625993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.